Metabolix, Inc. YTENQ

Growth Flags show if company had growth for consecutive years

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23
P/E ratio 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
P/S ratio 8.43 7.09 14.90 3.10 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
P/FCF ratio 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
P/Operating CF (4.04) (3.53) (4.10) (0.78) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
P/B ratio 1.53 0.53 1.45 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Price to Tangible BV 1.53 0.53 1.45 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
EV/Sales 3.10 (7.16) 16.16 (5.45) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
EV/EBITDA 0.00 0.74 0.00 0.52 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
EV/Operating CF (0.25) 0.82 (1.03) 0.51 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
EV/FCF (0.24) 0.79 (1.02) 0.50 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Quick Ratio 2.72 6.15 3.61 5.08 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Current Ratio 2.85 6.28 3.89 5.29 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Debt/EBITDA 0.63 1.60 (0.08) 0.82 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Debt/Assets 10.53% 0.00% 49.88% 25.25% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Debt/Equity 0.18 0.00 1.13 (1.03) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Asset Turnover 0.08 0.07 0.04 0.05 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡
Operating CF/Net income 1.89 0.76 0.95 0.67 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Capex/Depreciation (1.46) (0.03) (0.21) (0.30) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Depreciation/Fixed assets 0.30 0.13 0.14 0.16 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Interest Coverage 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
ROE (78.40%) (113.61%) (99.93%) (1,606.45%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
ROA (54.63%) (78.34%) (61.56%) (87.31%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
ROIC (3,335.94%) 0.00% (91.09%) 0.00% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Cash ROIC (109.00%) (34.80%) (56.54%) (87.95%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Return on Tangible Assets (111.15%) (76.86%) (150.06%) (120.86%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Accounts Receivable Turnover 3.21 6.15 3.99 6.40 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Accounts Payable Turnover 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Inventory Turnover 0.00 ‡‡‡ ‡‡‡
Average Days of Receivables 59.21 46.01 105.04 41.66 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Average Days of Payables 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Days of Inventory on Hand 0.00 ‡‡‡ ‡‡‡
Research and Development Expense of Revenue 489.21% 486.97% 860.25% 601.49% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Selling, General and Administrative Expense of Revenue 495.00% 596.40% 915.83% 565.01% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Intangible Assets out of Total Assets 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
Share Based Compensation of Revenue 73.17% 147.78% 212.41% 81.39% ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Graham Net Nets 0.36 1.72 (0.11) (3.64) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Graham Number 0.00 0.00 0.00 2,277.61 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡‡‡
Earnings Yield (82.56%) (157.92%) (111.96%) (521.07%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Free Cash Flow Yield (155.10%) (128.09%) (106.15%) (348.25%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue per Share 399.66 277.65 53.46 53.03 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Operating CF per Share (4,966.90) (2,412.35) (841.73) (569.34) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Capex per Share (259.31) (1.76) (4.04) (4.01) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Free Cash Flow per Share (5,226.21) (2,414.12) (845.77) (573.36) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash per Share 2,520.34 4,260.88 554.71 731.38 ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shareholders Equity per Share 2,196.21 3,971.18 547.88 (268.75) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Interest Debt per Share 0.00 0.00 0.00 0.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Book value per Share 2,196.21 3,971.18 547.88 (268.75) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Free Cash Flow (15.16) (8.21) (8.80) (8.71) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Working Capital 5.10 12.54 4.74 9.48 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Capital Expenditures (0.75) (0.01) (0.04) (0.06) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Current Asset Value 3.48 11.54 (0.88) (9.12) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Receivables 0.36 0.15 0.14 0.13 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Payables 0.09 0.07 0.10 0.20 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Inventory 0.12
Average Assets 13.92 13.82 14.92 14.84 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Average Common Equity 9.70 9.53 9.19 0.81 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
EV/EBIT 0.00 0.73 0.00 0.51 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡
Capex to Sales 0.65 0.01 0.08 0.08 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Profit Margin (656.08%) (1,146.50%) (1,651.98%) (1,607.44%) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Price to Operating Income 0.00 0.00 0.00 0.00 ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡